If you need more lookups,
subscriptions start at $34 USD/month.
Upendra Argikar Location
Cambridge, MA, US
Upendra Argikar Work
Head of DMPK @ (August 2021 - Present)
Editorial Board Member of Xenobiotica @ (August 2016 - Present)
Editorial Board Member @ (January 2017 - Present)
Editorial Board Member @ (January 2022 - Present)
Steering Committee Member @ (January 2015 - Present)
Editorial Advisory Board Member of Drug Metabolism and Disposition @ (January 2013 - Present)
Editorial Board Member of Drug Metabolism Letters @ (January 2016 - January 2021)
Investigator and Senior Investigator and Group Leader and Section Head @ (January 2006 - January 2021)
Vince Fellow @ (January 2005 - January 2006)
Mass Spectrometry Lab Associate, College of Pharmacy @ (January 2004 - January 2006)
Melendy Fellow @
Upendra Argikar Education
University of Mumbai
Bachelor of Pharmacy (Pharmaceutical Sciences)
University of Minnesota
Doctor of Philosophy (Medicinal Chemistry)
Upendra Argikar Skills
Drug Discovery
Drug Metabolism
Drug Development
Pharmacokinetics
ADME
HPLC
Pharmaceutical Industry
Chromatography
Life Sciences
Biotechnology
Pharmacology
Biochemistry
LC-MS
In Vitro
High-Performance Liquid Chromatography (HPLC)
Medicinal Chemistry
High Performance Liquid Chromatography Hplc
Mass Spectrometry
Biotransformation
Lc Ms
High Performance Liquid Chromatography
Upendra Argikar Summary
Upendra Argikar, based in Cambridge, MA, US, is currently a Head of DMPK at Gates Medical Research Institute. Upendra Argikar brings experience from previous roles at Xenobiotica, Current Drug Metabolism (IF 2.3), Drug Metabolism and Bioanalysis Letters and NEW ENGLAND DRUG METABOLISM DISCUSSION GROUP. Upendra Argikar holds a Bachelor of Pharmacy in Pharmaceutical Sciences @ University of Mumbai. With a robust skill set that includes Drug Discovery, Drug Metabolism, Drug Development, Pharmacokinetics, ADME and more. Upendra Argikar has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Upendra Argikar?
Find contact details for 700 million professionals.